HitGen LTD-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014272
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company offers OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It provides biological reagents, edge technology and services for progression of projects and services. HitGen’s services include lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, and others. It serves contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HitGen Enters into Agreement with Takeda Pharma 10
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 11
HitGen Enters into Agreement with Aduro Biotech 12
HitGen Enters into Research Agreement with LEO Pharma 13
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 14
HitGen Enters into Agreement with Merck 15
HitGen Enters into Agreement with Janssen Biotech 16
HitGen Enters into Research Agreement with Global Blood Therapeutics 17
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 18
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 19
Licensing Agreements 20
Pfizer Enters into Licensing Agreement with HitGen 20
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 21
HitGen LTD – Key Competitors 22
HitGen LTD – Key Employees 23
HitGen LTD – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HitGen LTD, Deals By Therapy Area, 2011 to YTD 2017 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
HitGen Enters into Agreement with Takeda Pharma 10
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 11
HitGen Enters into Agreement with Aduro Biotech 12
HitGen Enters into Research Agreement with LEO Pharma 13
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 14
HitGen Enters into Agreement with Merck 15
HitGen Enters into Agreement with Janssen Biotech 16
HitGen Enters into Research Agreement with Global Blood Therapeutics 17
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 18
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 19
Pfizer Enters into Licensing Agreement with HitGen 20
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 21
HitGen LTD, Key Competitors 22
HitGen LTD, Key Employees 23
HitGen LTD, Subsidiaries 24

★海外企業調査レポート[HitGen LTD-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dignity Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Dignity Health is a healthcare service provider that provides patient care services. The center providesclinical services in the areas of oncology, emergency, outpatient, general medical-surgical, palliative care, cardiology, rehabilitation and psychiatry, among others. It also offers physic …
  • Topcon Corp (7732):医療機器:M&Aディール及び事業提携情報
    Summary Topcon Corp (Topcon) is a medical device company that offers positioning and smart infrastructure and eye care products. The company provides positioning and smart infrastructure products which include TOCON and SOKKIA products. Topcon offers GNSS, total station, 3D scanner, machine control, …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Landesbank Hessen Thueringen Girozentrale:企業の戦略・SWOT・財務情報
    Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report Summary Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Hyperstone GmbH:企業の戦略的SWOT分析
    Hyperstone GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Allied Cooperative Insurance Group:企業の戦略・SWOT・財務情報
    Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Franz Haniel & Cie. GmbH:企業の戦略的SWOT分析
    Franz Haniel & Cie. GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Viamet Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …
  • Geisinger Health System-製薬・医療分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …
  • Panoramic Resources Ltd:企業の戦略・SWOT・財務情報
    Panoramic Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Panoramic Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Allinky Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • Younicos AG:電力:M&Aディール及び事業提携情報
    Summary Younicos AG (Younicos), a subsidiary of Aggreko Plc, is a provider of smart energy and grid solutions based on battery storage technology. The company offers Y-Cube plug and play energy storage solution, Y-Station building solution, and Y-Q software platform. It also provides battery packs u …
  • Wirtgen GmbH:企業の戦略・SWOT・財務情報
    Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report Summary Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Polycom Inc:企業の戦略的SWOT分析
    Polycom Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務情報
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆